Bank of New York Mellon Corp - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 109 filers reported holding AXSOME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,741,937
+1.4%
168,006
+4.3%
0.00%
+50.0%
Q2 2023$11,575,641
+50.0%
161,086
+28.7%
0.00%0.0%
Q1 2023$7,717,155
-22.1%
125,116
-2.6%
0.00%0.0%
Q4 2022$9,911,050
+64.3%
128,498
-4.9%
0.00%
+100.0%
Q3 2022$6,031,000
+34.1%
135,130
+15.1%
0.00%0.0%
Q2 2022$4,497,000
+3.0%
117,410
+11.4%
0.00%0.0%
Q1 2022$4,364,000
-5.3%
105,423
-13.6%
0.00%0.0%
Q4 2021$4,608,000
-4.5%
121,979
-16.7%
0.00%0.0%
Q3 2021$4,827,000
-48.3%
146,406
+5.9%
0.00%
-50.0%
Q2 2021$9,329,000
+13.6%
138,299
-4.6%
0.00%0.0%
Q1 2021$8,209,000
-33.0%
144,974
-3.6%
0.00%
-33.3%
Q4 2020$12,255,000
+15.8%
150,419
+1.3%
0.00%0.0%
Q3 2020$10,584,000
-12.5%
148,559
+1.0%
0.00%0.0%
Q2 2020$12,099,000
+34.3%
147,039
-4.0%
0.00%0.0%
Q1 2020$9,011,000
-40.5%
153,181
+4.5%
0.00%
-25.0%
Q4 2019$15,155,000
+355.2%
146,625
-10.8%
0.00%
+300.0%
Q3 2019$3,329,000
-21.4%
164,451
+0.0%
0.00%0.0%
Q2 2019$4,233,000
+238.6%
164,396
+87.2%
0.00%
Q1 2019$1,250,000
+1175.5%
87,841
+153.2%
0.00%
Q4 2018$98,000
+11.4%
34,690
+52.7%
0.00%
Q1 2017$88,000
-57.7%
22,723
-26.5%
0.00%
Q4 2016$208,000
+23.1%
30,918
+44.8%
0.00%
Q3 2016$169,000
+5.0%
21,3540.0%0.00%
Q2 2016$161,000
+50.5%
21,354
+85.5%
0.00%
Q4 2015$107,00011,5120.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 788,263$35,172,00044.43%
Fairmount Funds Management LLC 1,896,647$84,628,00014.88%
ACT CAPITAL MANAGEMENT, LLC 73,000$3,257,0004.50%
Ghost Tree Capital, LLC 300,000$13,386,0003.76%
Ikarian Capital, LLC 407,600$18,188,0003.62%
Paradigm Biocapital Advisors LP 520,080$23,206,0003.09%
MORGAN JESS S & CO INC 78,895$3,520,0003.06%
PFM Health Sciences, LP 1,659,733$74,057,0002.68%
RTW INVESTMENTS, LP 1,882,164$83,982,0001.94%
Ghost Tree Capital, LLC 150,000$6,693,0001.88%
View complete list of AXSOME THERAPEUTICS INC shareholders